Vividion Therapeutics

Vividion Therapeutics

Acquired by
Bayer
1
05 Aug 2021
$2,000,000,000
Latest funding
$82,000,000
Venture capital (Series B) - 2019
Cardinal Partners Celgene Versant Ventures +7
$50,000,000
Venture capital (Series A) - 2017
ARCH Venture Partners Versant Ventures
$2,000,000,000
Reuters Top News

Bayer buys biopharma firm Vividion Therapeutics for up to $2 bln

PE HUB

Vividion Therapeutics picks up $50 mln Series A

Funding Messaging
$50,000,000 Venture capital (Series A)
businesswire

Vividion Therapeutics, Inc., Launches With $50 Million Series A Financing